The mathematician of the Complutense University of Madrid, José-Vidal Ruiz Varela, argues that Europe must raise its borrowing limit, leaving its deflationary policy.

Cotización de las Principales divisas en tiempo real

Cotización de las Principales divisas en tiempo real
e-mail : admin@fasesdelabolsa.net

Agenda Macro

Calendario económico en tiempo real proporcionado por Investing.com España.

martes, 24 de julio de 2012

Pfizer, J&J Alzheimer's drug falls short in study

SAN FRANCISCO (MarketWatch) 

Pfizer Inc.  PFE -0.42% said late Monday that an experimental Alzheimer's treatment it's working on with Johnson & Johnson Inc.  unit Janssen Pharmaceuticals did not meet clinical endpoints in a late-stage study

In the study, a certain class of patients with mild-to-moderate Alzheimer's disease given an intravenous form of the drug bapineuzumab did not fare any better in cognitive and functional performance compared with those given a placebo, Pfizer said

The Phase III drug study is one of four that Pfizer is partnering on with the J&J unit

The three other studies of the drug will continue as planned, Pfizer said

No hay comentarios: